fostriecin and Leukemia-P388

fostriecin has been researched along with Leukemia-P388* in 1 studies

Other Studies

1 other study(ies) available for fostriecin and Leukemia-P388

Article	Year
Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties. The Journal of antibiotics, 1983, Volume: 36, Issue:12 CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete characterized as Streptomyces pulveraceus subsp. fostreus ATCC 31906. The antitumor compounds are predominantly produced during the stationary (idiophase) growth phase of the organism. CI-920 is active versus the murine P388 lymphocytic and L1210 lymphoid leukemia with T/C values of 246 and 207, respectively. This compound has no significant antimicrobial activity. Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Drug Evaluation, Preclinical; Fermentation; Leukemia L1210; Leukemia P388; Mice; Microbial Sensitivity Tests; Polyenes; Pyrones; Streptomyces; Structure-Activity Relationship	1983

Article

Year

Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties.

The Journal of antibiotics, 1983, Volume: 36, Issue:12

CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete characterized as Streptomyces pulveraceus subsp. fostreus ATCC 31906. The antitumor compounds are predominantly produced during the stationary (idiophase) growth phase of the organism. CI-920 is active versus the murine P388 lymphocytic and L1210 lymphoid leukemia with T/C values of 246 and 207, respectively. This compound has no significant antimicrobial activity.

Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Drug Evaluation, Preclinical; Fermentation; Leukemia L1210; Leukemia P388; Mice; Microbial Sensitivity Tests; Polyenes; Pyrones; Streptomyces; Structure-Activity Relationship

1983